Yunqian Zhang1, Rui Peng1,2, Hongyan Wang1,2,3,4. 1. Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, State Key Laboratory of Genetic Engineering at School of Life Sciences, Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China. 2. NHC Key Lab of Reproduction (Shanghai Institute of Planned Parenthood Research), Collaborative Innovation Center of Genetics and Development, Fudan University, Shanghai, China. 3. Children's Hospital, Fudan University, Shanghai, China. 4. The Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Abstract
BACKGROUND: Myosin family genes, including those encoding myosin heavy chain 6, myosin heavy chain 7, myosin light chain 3, and myosin light chain 2 (MYL2), are important genetic factors in congenital heart disease (CHD). However, how these genes contribute to CHD in the Han Chinese population remains unclear. METHODS: We sequenced myosin family genes in a Han Chinese cohort comprising 412 CHD patients and 213 matched controls in the present study. A zebrafish model was used to evaluate the pathogenicity of rare mutations in MYL2. RESULTS: We identified 30 known mutations and 12 novel mutations. Furthermore, the contributions of two novel mutations, MYL2 p.Ile158Thr and p.Val146Met, to CHD were analyzed. The p.Ile158Thr mutation increased MYL2 expression. In zebrafish embryos, injection of myl2b-targeting morpholinos led to aberrant cardiac structures, an effect that was reversed by expression of wild-type MYL2 but not MYL2 p.Ile158Thr and pVal146Met. CONCLUSIONS: Overall, our findings suggest that MYL2 p.Ile158Thr and p.Val146Met contribute to the etiology of CHD. The results also indicate the importance of MYL2 in heart formation.
BACKGROUND: Myosin family genes, including those encoding myosin heavy chain 6, myosin heavy chain 7, myosin light chain 3, and myosin light chain 2 (MYL2), are important genetic factors in congenital heart disease (CHD). However, how these genes contribute to CHD in the Han Chinese population remains unclear. METHODS: We sequenced myosin family genes in a Han Chinese cohort comprising 412 CHD patients and 213 matched controls in the present study. A zebrafish model was used to evaluate the pathogenicity of rare mutations in MYL2. RESULTS: We identified 30 known mutations and 12 novel mutations. Furthermore, the contributions of two novel mutations, MYL2 p.Ile158Thr and p.Val146Met, to CHD were analyzed. The p.Ile158Thr mutation increased MYL2 expression. In zebrafish embryos, injection of myl2b-targeting morpholinos led to aberrant cardiac structures, an effect that was reversed by expression of wild-type MYL2 but not MYL2 p.Ile158Thr and pVal146Met. CONCLUSIONS: Overall, our findings suggest that MYL2 p.Ile158Thr and p.Val146Met contribute to the etiology of CHD. The results also indicate the importance of MYL2 in heart formation.
Authors: Javier T Granados-Riveron; Tushar K Ghosh; Mark Pope; Frances Bu'Lock; Christopher Thornborough; Jacqueline Eason; Edwin P Kirk; Diane Fatkin; Michael P Feneley; Richard P Harvey; John A L Armour; J David Brook Journal: Hum Mol Genet Date: 2010-07-23 Impact factor: 6.150
Authors: J Erdmann; S Daehmlow; S Wischke; M Senyuva; U Werner; J Raible; N Tanis; S Dyachenko; M Hummel; R Hetzer; V Regitz-Zagrosek Journal: Clin Genet Date: 2003-10 Impact factor: 4.438
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547
Authors: Augusto C Montezano; Livia De Lucca Camargo; Patrik Persson; Francisco J Rios; Adam P Harvey; Aikaterini Anagnostopoulou; Roberto Palacios; Ana Caroline P Gandara; Rheure Alves-Lopes; Karla B Neves; Maria Dulak-Lis; Chet E Holterman; Pedro Lagerblad de Oliveira; Delyth Graham; Christopher Kennedy; Rhian M Touyz Journal: J Am Heart Assoc Date: 2018-06-15 Impact factor: 5.501